Retraction

The correlation of plasma microRNA-200 family expressions with risk and disease severity of lupus nephritis

Paper Information

Record ID:
30714
Publication Date:
May 01, 2021
Retraction Date:
May 01, 2021 (4.6 years years ago)
Article Type:
Publisher:
Verduci Editore
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:

Retraction Details

Nature of Retraction:

Retraction

Citations (13)

13
Total Citations
7
Post-Retraction
(53.8%)
6
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
4 Within 1 year
0 After 2+ years
673 Days since retraction (latest)
MicroRNA-200c-5p Regulates Migration and Differentiation of Myoblasts via Targeting Adamts5 in Skeletal Muscle Regeneration and Myogenesis
Liu Yan-wen, Yilong Yao, Yongsheng Zhang et al. (12 authors)
International Journal of Molecular Sciences Open Access
Published: Mar 2023
7 citations
673 days after retraction
Dysregulated MicroRNAs in the Pathogenesis of Systemic Lupus Erythematosus: A Comprehensive Review
Daeun Choi, Jimin Kim, Jae Won Yang et al. (6 authors)
International Journal of Biological Sciences Open Access
Published: Jan 2023
10 citations
610 days after retraction
Is there a potential of circulating miRNAs as biomarkers in rheumatic diseases?
Klára Prajzlerová, Ladislav Šenolt, Mária Filková
Genes & Diseases Open Access
Published: Sep 2022
8 citations
494 days after retraction
Emerging Molecular Markers Towards Potential Diagnostic Panels for Lupus
Gongjun Tan, Binila Baby, Yuqiu Zhou et al. (4 authors)
Frontiers in Immunology Open Access
Published: Jan 2022
29 citations
257 days after retraction
Plasma circPTPN22 and its potential target microRNA-200a-3p as novel diagnostic biomarkers in systemic lupus erythematosus patients
Hagar Lotfy Mowafy, Maha Kotb, Kamal Maurice Hanna et al. (5 authors)
The Egyptian Rheumatologist Open Access
Published: Nov 2021
1 citation
193 days after retraction
Differential expression of circulating microRNAs in serum: Potential biomarkers to track Japanese encephalitis virus infection
Manjari Baluni, Sneha Ghildiyal, Tanzeem Fatima et al. (8 authors)
Journal of Medical Virology
Published: Oct 2021
9 citations
178 days after retraction
miR‐141‐5p suppresses vascular smooth muscle cell inflammation, proliferation, and migration via inhibiting the HMGB1/NF‐κB pathway
Yadong Li, Haide Li, Bin Chen et al. (5 authors)
Journal of Biochemical and Molecular Toxicology
Published: Jun 2021
15 citations
44 days after retraction
Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage
Chang‐Youh Tsai, Chieh‐Yu Shen, Chih‐Wei Liu et al. (12 authors)
Biomolecules Open Access
Published: Dec 2020
29 citations
146 days before retraction
Serum long noncoding RNAs FAS-AS1 & PVT1 are novel biomarkers for systemic lupus erythematous
Marwa A. Ali, Olfat Shaker, Abeer A. Khalefa et al. (10 authors)
British Journal of Biomedical Science
Published: Jul 2020
18 citations
303 days before retraction
Exploring the Role of Non-Coding RNAs in the Pathophysiology of Systemic Lupus Erythematosus
Mohammad Taheri, Reyhane Eghtedarian, Marcel E. Dinger et al. (4 authors)
Biomolecules Open Access
Published: Jun 2020
38 citations
313 days before retraction
[Expression and diagnostic value of plasma miR-145 and miR-183 in children with lupus nephritis].
Lie-Ju Lin, Lang-Jun Mai, Guang Chen et al. (6 authors)
PubMed
Published: Jun 2020
9 citations
334 days before retraction
Downregulated miR-203 attenuates IL-β, IL-6, and TNF-α activation in TRAF6-treated human renal mesangial and tubular epithelial cells.
Li Zhang, Xingkun Zhang
PubMed
Published: Jan 2020
11 citations
486 days before retraction
Diagnostic significance of circulating miRNAs in systemic lupus erythematosus
Xiaolan Zheng, Yi Zhang, Yue Peng et al. (9 authors)
PLoS ONE Open Access
Published: Jun 2019
19 citations
697 days before retraction
Quick Stats
Total Citations: 13
Years Since Retraction: 4.6 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Effect of propofol on myocardial ischemia-reperfusion injur…
European Review for Medical and Pharmacological Sciences • 19 citations
MiR-299-3p inhibits proliferation and invasion of cervical …
European Review for Medical and Pharmacological Sciences • 19 citations
Aldose reductase inhibitor Epalrestat alleviates high gluco…
European Review for Medical and Pharmacological Sciences • 18 citations
MiR-15a-3p suppresses the growth and metastasis of ovarian …
European Review for Medical and Pharmacological Sciences • 18 citations
The inhibitory effect of miR-375 targeting sp1 in colorecta…
European Review for Medical and Pharmacological Sciences • 18 citations